Funded Research

Mechanism for SHOX Proteins to Regulate Skeletal Growth
Principal Investigator(s):
Status:
Completed
Center(s):
  • Center for Metabolism and Immunity
Award Mechanism:
Interdisciplinary Research Initiative
Project Period:
2/1/2008 - 1/31/2011
Total Amount:
$200,000
Mutations in transcription factors that control specific gene expression patterns in bone morphogenesis lead to congenital skeletal dysplasias. Dr. Long is a recognized expert in this area, who with basic science and clinical collaborators, will define the pathways from loss of a transcription factor to abnormal bone cell development and investigate these pathways in children with congenital skeletal dysplasia. These studies have the potential to identify new therapeutic targets along this pathway that could be manipulated to regenerate limb growth in affected children with musculoskeletal defects.